In line with these formerly reported cases6, FA patients with biallelic BRCA2 pathogenic variants previously identified in our laboratory presented elevated chromosomal fragility, severe congenital aberrations and/or high cancer incidence by age 3 or younger (Table S1). This evidence concerns the gene BRCA2 and cancer.